巴尔通体心内膜炎相关性肾小球肾炎:自身免疫和血管炎的模拟物

IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY
Nicole K. Andeen , Vanderlene L. Kung , Jane K. Nguyen , Rupali S. Avasare , Georges N. Nakhoul , Nabin K. Shrestha , Jina T. Makadia , Tricia Jesperson , Cynthia C. Nast , Grace (Hae Yoon) Choung , Leal Herlitz
{"title":"巴尔通体心内膜炎相关性肾小球肾炎:自身免疫和血管炎的模拟物","authors":"Nicole K. Andeen ,&nbsp;Vanderlene L. Kung ,&nbsp;Jane K. Nguyen ,&nbsp;Rupali S. Avasare ,&nbsp;Georges N. Nakhoul ,&nbsp;Nabin K. Shrestha ,&nbsp;Jina T. Makadia ,&nbsp;Tricia Jesperson ,&nbsp;Cynthia C. Nast ,&nbsp;Grace (Hae Yoon) Choung ,&nbsp;Leal Herlitz","doi":"10.1016/j.ekir.2025.01.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div><em>Bartonella spp.</em> are highly fastidious gram-negative facultative intracellular bacteria which can cause a culture-negative infective endocarditis (IE) with unique clinicopathologic features.</div></div><div><h3>Methods</h3><div>In this study, we assembled 20 cases of glomerulonephritis (GN) due to <em>Bartonella</em> IE from 3 institutions and compared them with 49 cases of culture-positive IEGN and 30 cases of non-endocarditis infection-related GN (IRGN).</div></div><div><h3>Results</h3><div>IEGN was seen in approximately 0.15% to 0.4% of native renal biopsies, with <em>Bartonella</em> causing 8% to 21% of IEGN. Patients with <em>Bartonella</em> IEGN had preexisting cardiac valve alterations (75%); antineutrophil cytoplasmic autoantibody (ANCA) positivity (67%); hypocomplementemia (75%); antinuclear antibody positivity (53%); cryoglobulinemia (45%); and hematologic manifestations, including B-symptoms (79%), splenomegaly (59%), thrombocytopenia (83%), and pancytopenia (44%). In 75% of the cases, <em>Bartonella</em> endocarditis was not diagnosed until after kidney biopsy. Pathologically, <em>Bartonella</em> IEGN presented as a focally crescentic GN, which was C3 codominant (80%) with strong IgM (65%) and/or C1q (55%), or pauci-immune (10%), with predominantly mesangial deposits and limited exudative features. At a median follow-up time of 15 months, progression to end-stage kidney disease (ESKD) for all-comers with IEGN was associated with higher creatinine levels at diagnosis, presence of nephrotic syndrome, female sex, and C1q staining intensity. Although delayed diagnosis of infection and immunosuppressive therapy for presumed autoimmune disease before kidney biopsy were more common in <em>Bartonella</em> IEGN than in culture-positive IEGN, neither were associated with ESKD.</div></div><div><h3>Conclusion</h3><div>IEGNs share laboratory and biopsy features with autoimmunity, which may obfuscate identification of underlying bacterial infection.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"10 4","pages":"Pages 1237-1247"},"PeriodicalIF":5.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bartonella Endocarditis-Associated Glomerulonephritis: A Mimicker of Autoimmunity and Vasculitis\",\"authors\":\"Nicole K. Andeen ,&nbsp;Vanderlene L. Kung ,&nbsp;Jane K. Nguyen ,&nbsp;Rupali S. Avasare ,&nbsp;Georges N. Nakhoul ,&nbsp;Nabin K. Shrestha ,&nbsp;Jina T. Makadia ,&nbsp;Tricia Jesperson ,&nbsp;Cynthia C. Nast ,&nbsp;Grace (Hae Yoon) Choung ,&nbsp;Leal Herlitz\",\"doi\":\"10.1016/j.ekir.2025.01.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div><em>Bartonella spp.</em> are highly fastidious gram-negative facultative intracellular bacteria which can cause a culture-negative infective endocarditis (IE) with unique clinicopathologic features.</div></div><div><h3>Methods</h3><div>In this study, we assembled 20 cases of glomerulonephritis (GN) due to <em>Bartonella</em> IE from 3 institutions and compared them with 49 cases of culture-positive IEGN and 30 cases of non-endocarditis infection-related GN (IRGN).</div></div><div><h3>Results</h3><div>IEGN was seen in approximately 0.15% to 0.4% of native renal biopsies, with <em>Bartonella</em> causing 8% to 21% of IEGN. Patients with <em>Bartonella</em> IEGN had preexisting cardiac valve alterations (75%); antineutrophil cytoplasmic autoantibody (ANCA) positivity (67%); hypocomplementemia (75%); antinuclear antibody positivity (53%); cryoglobulinemia (45%); and hematologic manifestations, including B-symptoms (79%), splenomegaly (59%), thrombocytopenia (83%), and pancytopenia (44%). In 75% of the cases, <em>Bartonella</em> endocarditis was not diagnosed until after kidney biopsy. Pathologically, <em>Bartonella</em> IEGN presented as a focally crescentic GN, which was C3 codominant (80%) with strong IgM (65%) and/or C1q (55%), or pauci-immune (10%), with predominantly mesangial deposits and limited exudative features. At a median follow-up time of 15 months, progression to end-stage kidney disease (ESKD) for all-comers with IEGN was associated with higher creatinine levels at diagnosis, presence of nephrotic syndrome, female sex, and C1q staining intensity. Although delayed diagnosis of infection and immunosuppressive therapy for presumed autoimmune disease before kidney biopsy were more common in <em>Bartonella</em> IEGN than in culture-positive IEGN, neither were associated with ESKD.</div></div><div><h3>Conclusion</h3><div>IEGNs share laboratory and biopsy features with autoimmunity, which may obfuscate identification of underlying bacterial infection.</div></div>\",\"PeriodicalId\":17761,\"journal\":{\"name\":\"Kidney International Reports\",\"volume\":\"10 4\",\"pages\":\"Pages 1237-1247\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney International Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2468024925000099\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney International Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468024925000099","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

巴尔通体是高度挑剔的革兰氏阴性兼性细胞内细菌,可引起培养阴性的感染性心内膜炎(IE),具有独特的临床病理特征。方法收集3所医院的20例巴尔通体IE所致肾小球肾炎(GN)病例,并与49例ien培养阳性病例和30例非心内膜炎感染相关性肾小球肾炎(IRGN)病例进行比较。结果约0.15% ~ 0.4%的原生肾活检可见egn,巴尔通体引起egn的8% ~ 21%。巴尔通体IEGN患者先前存在心脏瓣膜改变(75%);抗中性粒细胞胞浆自身抗体(ANCA)阳性(67%);hypocomplementemia (75%);抗核抗体阳性(53%);冷沉球蛋白血症(45%);血液学表现,包括b症状(79%)、脾肿大(59%)、血小板减少(83%)和全血细胞减少(44%)。在75%的病例中,直到肾活检后才诊断出巴尔通体心内膜炎。病理上,巴尔通体IEGN表现为局灶月牙状GN, C3共显性(80%),伴有强IgM(65%)和/或C1q(55%),或缺乏免疫(10%),主要有系膜沉积和有限渗出特征。在中位随访时间为15个月时,患有IEGN的所有患者进展为终末期肾病(ESKD)与诊断时较高的肌酐水平、肾病综合征的存在、女性和C1q染色强度相关。尽管在IEGN培养阳性的bar通体患者中,延迟诊断感染和在肾活检前对假定的自身免疫性疾病进行免疫抑制治疗更为常见,但两者都与ESKD无关。结论iegns与自身免疫具有相同的实验室和活检特征,这可能会混淆潜在细菌感染的识别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Bartonella Endocarditis-Associated Glomerulonephritis: A Mimicker of Autoimmunity and Vasculitis

Bartonella Endocarditis-Associated Glomerulonephritis: A Mimicker of Autoimmunity and Vasculitis

Introduction

Bartonella spp. are highly fastidious gram-negative facultative intracellular bacteria which can cause a culture-negative infective endocarditis (IE) with unique clinicopathologic features.

Methods

In this study, we assembled 20 cases of glomerulonephritis (GN) due to Bartonella IE from 3 institutions and compared them with 49 cases of culture-positive IEGN and 30 cases of non-endocarditis infection-related GN (IRGN).

Results

IEGN was seen in approximately 0.15% to 0.4% of native renal biopsies, with Bartonella causing 8% to 21% of IEGN. Patients with Bartonella IEGN had preexisting cardiac valve alterations (75%); antineutrophil cytoplasmic autoantibody (ANCA) positivity (67%); hypocomplementemia (75%); antinuclear antibody positivity (53%); cryoglobulinemia (45%); and hematologic manifestations, including B-symptoms (79%), splenomegaly (59%), thrombocytopenia (83%), and pancytopenia (44%). In 75% of the cases, Bartonella endocarditis was not diagnosed until after kidney biopsy. Pathologically, Bartonella IEGN presented as a focally crescentic GN, which was C3 codominant (80%) with strong IgM (65%) and/or C1q (55%), or pauci-immune (10%), with predominantly mesangial deposits and limited exudative features. At a median follow-up time of 15 months, progression to end-stage kidney disease (ESKD) for all-comers with IEGN was associated with higher creatinine levels at diagnosis, presence of nephrotic syndrome, female sex, and C1q staining intensity. Although delayed diagnosis of infection and immunosuppressive therapy for presumed autoimmune disease before kidney biopsy were more common in Bartonella IEGN than in culture-positive IEGN, neither were associated with ESKD.

Conclusion

IEGNs share laboratory and biopsy features with autoimmunity, which may obfuscate identification of underlying bacterial infection.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Kidney International Reports
Kidney International Reports Medicine-Nephrology
CiteScore
7.70
自引率
3.30%
发文量
1578
审稿时长
8 weeks
期刊介绍: Kidney International Reports, an official journal of the International Society of Nephrology, is a peer-reviewed, open access journal devoted to the publication of leading research and developments related to kidney disease. With the primary aim of contributing to improved care of patients with kidney disease, the journal will publish original clinical and select translational articles and educational content related to the pathogenesis, evaluation and management of acute and chronic kidney disease, end stage renal disease (including transplantation), acid-base, fluid and electrolyte disturbances and hypertension. Of particular interest are submissions related to clinical trials, epidemiology, systematic reviews (including meta-analyses) and outcomes research. The journal will also provide a platform for wider dissemination of national and regional guidelines as well as consensus meeting reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信